Management of high-grade, non-muscle invasive urothelial carcinoma in a pre-pubertal patient with TURBT and intravesical BCG

High-grade urothelial carcinoma (UC) of the bladder is rare in the pediatric population with no established guidelines for management. We treated a single female patient, 10 years of age, who was found to have high-grade, non-muscle invasive UC endoscopically and with intravesical BCG.  Given the child's age, no local adult institution could provide BCG therapy. Utilizing the experience of the local adult institutions, we developed a comprehensive protocol for first-time delivery of BCG at a free-standing children's hospital. The patient has undergone successful induction and maintenance BCG for 7 cycles without disease recurrence and minimal side effects.

Urology. 2018 Oct 23 [Epub ahead of print]

James Rague, Richard S Lee

Boston Medical Center, Department of Urology, Boston MA., Harvard Medical School, Department of Surgery and Boston Children's Hospital, Department of Urology, Boston, MA.


Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.